Brind.
  1. Multiple pharmaceutical giants, including Eli Lilly, Amgen, and Novo Nordisk, are developing obesity drugs for the market.

Amgen acquired Onyx Pharmaceuticals for $10 billion, while Eric Groen graduated from UC and joined the executive team at Genelux Corporation.

1 report, 0 independent Updated Jul 7
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Amgen acquired Onyx Pharmaceuticals for $10 billion, while Eric Groen graduated from UC and joined the executive team at Genelux Corporation.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet